Replies to post #185999 on Biotech Values

[GrthzGd]

As an aside, it's too bad ABBV can't recover from the US DOC the $1.5B break fee it was forced to pay to Shire last summer due to the DOC's changing the tax rules as they affected offshoring without prior notice or opportunity for comment.